Delayed Danish state Covid vaccine to be trialled on humans in 2022

Denmark's second coronavirus vaccine, Covaxix, which is being developed by National Danish infectious disease research organization Statens Serum Insitut (SSI), has come closer to being tested on humans in phase I and II trials in 2022 after a string of delays.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app